https://doi.org/10.1016/j.isci.2021.102711
M
Mathieu Surénaud
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
2.2K
Citations
27
h-index
41
i10-index
Mathieu Surénaud is an academic researcher from Inserm. The author has contributed to research in topics: Immunotherapy and Immune Responses & HIV Research and Treatment & COVID-19 Clinical Research Studies. The author has an h-index of 27, co-authored 81 publications.
ORCID: 0000-0002-3312-7871Papers by this author
worksCD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
2021 · iScience · 149 citations
Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS
2021 · Critical Care · 56 citations
https://doi.org/10.1186/s13054-020-03427-y
A multiplex analysis of sepsis mediators during human septic shock: a preliminary study on myocardial depression and organ failures
2019 · Annals of Intensive Care · 37 citations
https://doi.org/10.1186/s13613-019-0538-3
A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease
2024 · Cell Reports Medicine · 15 citations
https://doi.org/10.1016/j.xcrm.2024.101467
Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells
2016 · BMC Immunology · 12 citations
https://doi.org/10.1186/s12865-016-0182-8
Symptoms and pathophysiology of post-acute sequelae following COVID-19 (PASC): a cohort study
2025 · EBioMedicine · 7 citations
https://doi.org/10.1016/j.ebiom.2025.105792
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat